CNCR Loncar Cancer Immunotherapy ETF

USD 15.86 0.00 0
Icon

Loncar Cancer Immunotherapy ETF (CNCR) Stock Analysis and Price Targets

ETF | Health | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 15.86

0.00 (0.00)%

USD 0.02B

5.95K

USD -1.00

N/A

Icon

CNCR

Loncar Cancer Immunotherapy ETF (USD)
ETF | NSD
USD 15.86
0.00 0
Take a Tour

Loncar Cancer Immunotherapy ETF (CNCR) Stock Forecast

N/A

Based on the Loncar Cancer Immunotherapy ETF stock forecast from 0 analysts, the average analyst target price for Loncar Cancer Immunotherapy ETF is not available over the next 12 months. Loncar Cancer Immunotherapy ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Loncar Cancer Immunotherapy ETF is Bearish, which is based on 1 positive signals and 4 negative signals. At the last closing, Loncar Cancer Immunotherapy ETF’s stock price was USD 15.86. Loncar Cancer Immunotherapy ETF’s stock price has changed by +10.22% over the past week, +1.02% over the past month and +16.36% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...